))
A Discussion with Brian Finn of Findell Capital: Biotech Investing, Liquidia & ProQR
Manage episode 337249290 series 3380517
Kandungan disediakan oleh Encode Ideas, L.P., Encode Ideas, and L.P.. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Encode Ideas, L.P., Encode Ideas, and L.P. atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
An interview with Brian Finn of Findell Capital, where we discuss his perspective on small-cap investing. During the interview, we discuss two of Brian's favorite health care names, Liquidia and ProQR, as well as his previous success with MiMedx. To learn more about Findell Capital please visit their website https://findell.us/
Companies discussed during the podcast;
- Liquidia Corporation (Nasdaq: LQDA)
- ProQR Therapeutics N.V. (Nasdaq: PRQR)
- MiMedx Group Inc (Nasdaq: MDXG)
- United Therapeutics Corporation (Nasdaq: UTHR)
- MannKind Corporation (Nasdaq: MNKD)
- Editas Medicine Inc (Nasdaq: EDIT)
7 episod
Kongsi
